Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, in North Carolina, he became the director of the UNC-Duke Proteomics Facility and held a faculty position at the UNC Medical School in Chapel Hill, NC (2001-2006). Since then, Dr. Borchers has been employed at the University of Victoria (UVic), Canada and holds the current positions of Professor in the Department of Biochemistry and Microbiology and the Don and Eleanor Rix BC Leadership Chair in Biomedical and Environmental Proteomics. He is also the Director of the UVic – Genome BC Proteomics Centre, which is one out of five Genome Canada funded Science & Technology Innovation Centres and the only one devoted to proteomics.
His research is centred around the improvement, development and application of proteomics technologies with a major focus on techniques for quantitative targeted proteomics for clinical diagnostics. Multiplexed LC-MRM-MS approaches and the immuno-MALDI (iMALDI) technique are of particular interest. Another focus of his research is on technology development and application of the combined approach of protein chemistry and mass spectrometry for structural proteomics. Dr. Borchers has published over 180 peer-reviewed papers in scientific journals and is the founder and CSO of two companies, Creative Molecules. Inc. and MRM Proteomics Inc. He is also involved in promoting proteomic research and education through his function as HUPO International Council Member, Scientific Director of the BC Proteomics Network and Vice-President, External of the Canadian National Proteomics Network.

Professor, Biomedical Physiology and Kinesiology, Simon Fraser University
Distinguished Scientist, Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency
Professor, Medical Genetics, University of British Columbia

Angie Brooks-Wilson leads the Cancer Genetics Laboratory of the Genome Sciences Centre at the British Columbia Cancer Agency. Her current work focuses on the genetics of susceptibility to cancer, particularly lymphoid cancers, in both families and populations, and the genetics of healthy aging. She leads the Genomics, Genetics and Gerontology (G3) Team for the Study of Healthy Aging, in which exceptionally healthy elderly individuals (‘Super-Seniors’) are helping to determine the genetic influences that contribute to healthy aging and protect against age-associated diseases.

PhD in Genetics from Harvard University
Lead author on Nature Genetics paper describing positional cloning of the first zebrafish mutation corresponding to a human disease (sideroblastic anemia), validating zebrafish as a model system
5 Nature/Nature Genetics Publications
Extensive project management experience with both CROs and corporate partners, coordinating activities of cross functional teams up to 20 FTEs
Combined 20 years of genetics expertise both academic and industrial settings

Dr. Alex MacKenzie, M.D., Ph.D, is a Full Professor in the Department of Pediatrics at the University of Ottawa with a cross appointment to the Department of Cellular and Molecular Medicine. He received his MD in 1983 and his PhD in Medical Biophysics in 1986, both from the University of Toronto. He received his pediatric certification in 1989 from the University of Ottawa and is a member of the attending staff at the Children’s Hospital of Eastern Ontario in Ottawa. From 2000 to 2010 he served as the CEO and Science Director of the Children’s Hospital of Eastern Ontario Research Institute as well as Vice President of Research for the Children’s Hospital of Eastern Ontario. He also served in 2003/2004 as Vice President of Research, Genome Canada. Dr. MacKenzie works on the molecular genetics of pediatric disease with current research focus on the molecular genetics of spinal muscular atrophy (SMA). Dr. MacKenzie has been the recipient of Medial Research Council Scientist and Burroughs Wellcome Clinical Scientist Awards. He has been awarded the Researcher of the Year award by the Muscular Dystrophy Association of Canada and a Champions of Genetics award by the Canadian GeneCure Foundation.

Dr Steidl is an Assistant Professor in the Department of Pathology (University of British Columbia) and Experimental Therapeutics (BC Cancer Agency). He is holding an MD degree from the University of Muenster, Germany, and a PhD equivalent degree from University of Witten-Herdecke, Germany. Dr Steidl has expertise in clinical malignant hematology, cytogenetics, molecular genetics, next generation sequencing and functional genomics. Dr Steidl joined the Centre for Lymphoid Cancer at the British Columbia Cancer Agency in 2006. He is currently supervising a translational research laboratory focusing on the pathogenesis of B cell lymphomas. Dr Steidl is most known for his work on biomarkers in Hodgkin lymphoma and discovery of somatic mutations and novel gene fusions in B cell lymphomas. He has authored 47 refereed articles in the field of hematological malignanices and has been an invited speaker at many conferences. He also serves as a member of the Lymphoma Research Foundation’s Panel of Scientific Advisors and the Medical Expert Committee of the Cancer Research Society. Dr Steidl holds research funding as the principle investigator by the Canadian Institutes of Health Research (CIHR), the Leukemia and Lymphoma Society of Canada (LLSC), the Canadian Hematology Society (CHS), the Terry Fox Research Institute (TFRI), the Canadian Cancer Society Research Institute (CCSRI) and is co-investigator on a Genome Canada grant to advance personalized treatments of lymphoid cancer patients. Dr Steidl also holds a career investigator award by the Michael-Smith Foundation for Health Research (MSFHR) and a New Investigator Award by CIHR.

Stuart Turvey, MBBS, DPhil, FRCPC is an Associate Professor of Pediatrics at the University of British Columbia where he holds the Aubrey J. Tingle Professorship in Pediatric Immunology. He is a Pediatric Immunologist based at BC Children’s Hospital, and Director of Clinical Research at the Child & Family Research Institute. Prior to coming to Vancouver, Dr Turvey completed both his Pediatric Residency and Allergy/Immunology Fellowship at Children’s Hospital, Harvard Medical School, Boston. He holds a medical degree (MB BS) from the University of Sydney, Australia and a doctorate (DPhil) in Immunology from Oxford University where he was a Rhodes Scholar. Dr Turvey is a Fellow of the Royal College of Physicians and Surgeons of Canada and a Diplomate of the American Board of Pediatrics.

Dr Turvey provides clinical care in the specialties of Clinical Immunology and Rheumatology, while his research program focuses on pediatric infectious and inflammatory diseases. Specifically, Dr Turvey is interested in the role of innate immunity in protecting infants and young children from infectious agents, and how abnormalities of the innate immune system contribute to inflammatory diseases of childhood.